These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 31672876)

  • 1. Crossing the line.
    Cohen J
    Science; 2019 Nov; 366(6465):562-565. PubMed ID: 31672876
    [No Abstract]   [Full Text] [Related]  

  • 2. Questioning the proposed translational pathway for germline genome editing.
    Baylis F
    Nat Hum Behav; 2019 Mar; 3(3):200. PubMed ID: 30953019
    [No Abstract]   [Full Text] [Related]  

  • 3. Human Genome Editing and Ethical Considerations.
    Krishan K; Kanchan T; Singh B
    Sci Eng Ethics; 2016 Apr; 22(2):597-9. PubMed ID: 26154417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. After the Storm - A Responsible Path for Genome Editing.
    Daley GQ; Lovell-Badge R; Steffann J
    N Engl J Med; 2019 Mar; 380(10):897-899. PubMed ID: 30649993
    [No Abstract]   [Full Text] [Related]  

  • 5. Momentous CRISPR-enabled developments.
    Nat Biomed Eng; 2019 Feb; 3(2):79-80. PubMed ID: 30944438
    [No Abstract]   [Full Text] [Related]  

  • 6. What CRISPR-baby prison sentences mean for research.
    Cyranoski D
    Nature; 2020 Jan; 577(7789):154-155. PubMed ID: 31911693
    [No Abstract]   [Full Text] [Related]  

  • 7. Bioethics. Embryo engineering alarm.
    Vogel G
    Science; 2015 Mar; 347(6228):1301. PubMed ID: 25792311
    [No Abstract]   [Full Text] [Related]  

  • 8. Rogues and Regulation of Germline Editing.
    Charo RA
    N Engl J Med; 2019 Mar; 380(10):976-980. PubMed ID: 30650001
    [No Abstract]   [Full Text] [Related]  

  • 9. The Moral Choices on CRISPR Babies.
    Krimsky S
    Am J Bioeth; 2019 Oct; 19(10):15-16. PubMed ID: 31557108
    [No Abstract]   [Full Text] [Related]  

  • 10. Shaping the CRISPR Gene-Editing Debate: Questions About Enhancement and Germline Modification.
    Johnston J
    Perspect Biol Med; 2020; 63(1):141-154. PubMed ID: 32063593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene editing and the health of future generations.
    Gyngell C
    J R Soc Med; 2017 Jul; 110(7):276-279. PubMed ID: 28445654
    [No Abstract]   [Full Text] [Related]  

  • 12. The Future of Gene Editing - Toward Scientific and Social Consensus.
    Rosenbaum L
    N Engl J Med; 2019 Mar; 380(10):971-975. PubMed ID: 30649992
    [No Abstract]   [Full Text] [Related]  

  • 13. Bioethics. Embryo engineering study splits scientific community.
    Kaiser J; Normile D
    Science; 2015 May; 348(6234):486-7. PubMed ID: 25931531
    [No Abstract]   [Full Text] [Related]  

  • 14. Germline Editing: Editors Cautionary.
    Krishan K; Kanchan T; Singh B; Baryah N; Puri S
    Clin Ter; 2018; 169(2):e58-e59. PubMed ID: 29595865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New gene editing technique CRISPR-Cas9 raises important ethical questions, says advisory body.
    Hawkes N
    BMJ; 2016 Sep; 354():i5318. PubMed ID: 27694221
    [No Abstract]   [Full Text] [Related]  

  • 16. Getting serious about the challenge of regulating germline gene therapy.
    Caplan A
    PLoS Biol; 2019 Apr; 17(4):e3000223. PubMed ID: 31039143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing Ethical Trials of Germline Gene Editing.
    Cwik B
    N Engl J Med; 2017 Nov; 377(20):1911-1913. PubMed ID: 29141166
    [No Abstract]   [Full Text] [Related]  

  • 18. [Application of clustered regularly interspaced short palindromic repeats- associated protein 9 gene editing technology for treatment of HBV infection].
    Wang YD; Liang QF; Li ZY; Zhao CY
    Zhonghua Gan Zang Bing Za Zhi; 2018 Nov; 26(11):860-864. PubMed ID: 30616324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Governing Human Germline Editing Through Patent Law.
    Sherkow JS; Adashi EY; Cohen IG
    JAMA; 2021 Sep; 326(12):1149-1150. PubMed ID: 34459849
    [No Abstract]   [Full Text] [Related]  

  • 20. The morality and ethics governing CRISPR-Cas9 patents in China.
    Peng Y
    Nat Biotechnol; 2016 Jun; 34(6):616-8. PubMed ID: 27281418
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.